{"id":281978,"date":"2026-10-01T09:30:46","date_gmt":"2026-10-01T04:00:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=281978"},"modified":"2026-10-01T09:30:46","modified_gmt":"2026-10-01T04:00:46","slug":"molbio-diagnostics-share-price-deal","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/","title":{"rendered":"HDFC Mutual Fund Buys a Rs 302 Crore Stake in Molbio Diagnostics as a Motilal Oswal PE Fund Exits"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Molbio Diagnostics Rs 1,313, up 0.3% (1 Oct, 9:13 AM). HDFC MF bought 1.99% for Rs 302.45 crore at Rs 1,315\/share from Motilal Oswal PE fund. P\/E 91.96 vs industry 66.60.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Molbio Diagnostics share price was Rs 1,313 at 9:13 AM on 1 October 2026, up 0.3 percent, after HDFC Mutual Fund acquired 23 lakh shares, a 1.99 percent stake in the Goa-based diagnostics company, for Rs 302.45 crore at Rs 1,315 apiece. Business Excellence Trust III, managed by Motilal Oswal Private Equity, sold 23.28 lakh shares for Rs 306.26 crore at Rs 1,315.01 per share, trimming its stake by 2.02 percentage points. The near-matching size of the buy and sell legs suggests this was a direct transfer between the private equity fund and HDFC Mutual Fund rather than broad market demand. Molbio trades at a P\/E of 91.96 against a diagnostics industry average of 66.60, a premium that reflects the company&#8217;s position in molecular diagnostics testing.<\/p>\n<\/div>\n<p>Molbio Diagnostics Limited, a Goa-based provider of diagnostic solutions known for its molecular testing platforms, saw a notable ownership change on Tuesday. HDFC Mutual Fund acquired 23 lakh shares, equivalent to a 1.99 percent stake, for Rs 302.45 crore at Rs 1,315 per share.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=molbio-diagnostics-share-price-deal\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<p>On the other side, Business Excellence Trust III, managed by Motilal Oswal Private Equity, pared its stake by 2.02 percentage points, offloading 23.28 lakh shares for Rs 306.26 crore at Rs 1,315.01 per share. This article covers the deal, the company&#8217;s valuation, and the risks behind the Molbio Diagnostics share price.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#What_the_HDFC_MF_Stake_Purchase_in_Molbio_Diagnostics_Shows\" title=\"What the HDFC MF Stake Purchase in Molbio Diagnostics Shows\">What the HDFC MF Stake Purchase in Molbio Diagnostics Shows<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Molbio_Diagnostics_Share_Price_Today_Numbers_and_Technical_Levels\" title=\"Molbio Diagnostics Share Price Today: Numbers and Technical Levels\">Molbio Diagnostics Share Price Today: Numbers and Technical Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Valuation_Behind_the_Molbio_Diagnostics_Share_Price\" title=\"Valuation Behind the Molbio Diagnostics Share Price\">Valuation Behind the Molbio Diagnostics Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Risks_for_the_Molbio_Diagnostics_Share_Price\" title=\"Risks for the Molbio Diagnostics Share Price\">Risks for the Molbio Diagnostics Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#What_is_the_Molbio_Diagnostics_share_price_today\" title=\"What is the Molbio Diagnostics share price today?\">What is the Molbio Diagnostics share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Who_bought_a_stake_in_Molbio_Diagnostics\" title=\"Who bought a stake in Molbio Diagnostics?\">Who bought a stake in Molbio Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Who_sold_shares_in_Molbio_Diagnostics\" title=\"Who sold shares in Molbio Diagnostics?\">Who sold shares in Molbio Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#What_does_Molbio_Diagnostics_do\" title=\"What does Molbio Diagnostics do?\">What does Molbio Diagnostics do?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Is_the_Molbio_Diagnostics_share_price_expensive\" title=\"Is the Molbio Diagnostics share price expensive?\">Is the Molbio Diagnostics share price expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#What_are_the_key_technical_levels_for_the_Molbio_Diagnostics_share_price\" title=\"What are the key technical levels for the Molbio Diagnostics share price?\">What are the key technical levels for the Molbio Diagnostics share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Why_did_a_private_equity_fund_sell_shares_in_Molbio_Diagnostics\" title=\"Why did a private equity fund sell shares in Molbio Diagnostics?\">Why did a private equity fund sell shares in Molbio Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-deal\/#Should_I_buy_Molbio_Diagnostics_shares_now\" title=\"Should I buy Molbio Diagnostics shares now?\">Should I buy Molbio Diagnostics shares now?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_the_HDFC_MF_Stake_Purchase_in_Molbio_Diagnostics_Shows\"><\/span><strong>What the HDFC MF Stake Purchase in Molbio Diagnostics Shows<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;\">Item<\/th>\n<th style=\"text-align:left;\">Detail<\/th>\n<\/tr>\n<tr>\n<td>Buyer<\/td>\n<td>HDFC Mutual Fund<\/td>\n<\/tr>\n<tr>\n<td>Shares bought<\/td>\n<td>23 lakh (1.99% stake)<\/td>\n<\/tr>\n<tr>\n<td>Value<\/td>\n<td>Rs 302.45 crore<\/td>\n<\/tr>\n<tr>\n<td>Seller<\/td>\n<td>Business Excellence Trust III (Motilal Oswal Private Equity)<\/td>\n<\/tr>\n<tr>\n<td>Shares sold<\/td>\n<td>23.28 lakh (2.02 percentage points)<\/td>\n<\/tr>\n<tr>\n<td>Value<\/td>\n<td>Rs 306.26 crore<\/td>\n<\/tr>\n<tr>\n<td>Price<\/td>\n<td>Rs 1,315 per share<\/td>\n<\/tr>\n<\/table>\n<p>A private equity fund trimming its stake years after an initial investment is a routine part of the fund&#8217;s own lifecycle, since such funds typically have defined holding periods before returning capital to their own investors. A large public mutual fund like HDFC stepping in to buy at the same price suggests continued institutional confidence in the company rather than a signal of concern.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/stocks-to-watch-today-01102026\">Stocks to Watch Today: Alicon Castalloy Jumps 20%, Ircon and Rites Surge on Heavy Volume<\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Molbio_Diagnostics_Share_Price_Today_Numbers_and_Technical_Levels\"><\/span><strong>Molbio Diagnostics Share Price Today: Numbers and Technical Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;\">Metric<\/th>\n<th style=\"text-align:left;\">Value (1 Oct, 9:13 AM)<\/th>\n<\/tr>\n<tr>\n<td>Molbio Diagnostics share price<\/td>\n<td>Rs 1,313.00 (up 0.3%)<\/td>\n<\/tr>\n<tr>\n<td>Previous close<\/td>\n<td>Rs 1,308.90<\/td>\n<\/tr>\n<tr>\n<td>52-week high \/ low<\/td>\n<td>Not fully available in the range checked<\/td>\n<\/tr>\n<tr>\n<td>RSI (14-day)<\/td>\n<td>31.9<\/td>\n<\/tr>\n<tr>\n<td>SuperTrend<\/td>\n<td>Bullish, support at Rs 1,180.54<\/td>\n<\/tr>\n<tr>\n<td>20-day average<\/td>\n<td>Rs 1,269.32<\/td>\n<\/tr>\n<tr>\n<td>Market cap<\/td>\n<td>Rs 15,090 crore<\/td>\n<\/tr>\n<tr>\n<td>P\/E vs industry P\/E<\/td>\n<td>91.96 vs 66.60<\/td>\n<\/tr>\n<tr>\n<td>Return on equity<\/td>\n<td>14.25%<\/td>\n<\/tr>\n<\/table>\n<p>The Molbio Diagnostics share price trades above its 20-day average of Rs 1,269.32, with an RSI of 31.9 that is close to oversold territory despite the stock sitting in a broader uptrend. The SuperTrend indicator remains bullish with support at Rs 1,180.54.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Healthcare and Diagnostics Stocks on the Univest Screener<\/strong><\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Valuation_Behind_the_Molbio_Diagnostics_Share_Price\"><\/span><strong>Valuation Behind the Molbio Diagnostics Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Molbio trades at a P\/E of 91.96 against a diagnostics industry average of 66.60, a premium built on the company&#8217;s position in molecular point-of-care testing, a segment that saw significant growth since the COVID-19 pandemic. Return on equity of 14.25 percent and debt to equity of 0.38 are reasonable for a growth-stage diagnostics company.<\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Risks_for_the_Molbio_Diagnostics_Share_Price\"><\/span><strong>Risks for the Molbio Diagnostics Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Valuation risk is the primary concern, since a P\/E nearly 40 percent above the industry average requires sustained growth to justify the premium. Regulatory and reimbursement risk in the diagnostics testing space, where government procurement and health policy can affect demand, is a second factor. Further private equity exits, as holding periods for pre-listing investors continue to run their course, are a third risk that could periodically add supply to the stock.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the Molbio Diagnostics share price and get alerts on block deals.<\/em><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Molbio Diagnostics share price held steady after HDFC Mutual Fund bought a Rs 302 crore stake as a Motilal Oswal private equity fund trimmed its holding at the same price. A bullish technical trend and continued institutional interest are supports, while a valuation premium to the diagnostics industry and the prospect of further private equity exits are risks. Investors deciding whether to buy Molbio Diagnostics shares should watch the Rs 1,269.32 average as support, follow stop-loss levels and consult a SEBI-registered adviser.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_is_the_Molbio_Diagnostics_share_price_today\"><\/span><strong>What is the Molbio Diagnostics share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Molbio Diagnostics share price was Rs 1,313 at 9:13 AM on 1 October 2026, up 0.3 percent from Rs 1,308.90.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Who_bought_a_stake_in_Molbio_Diagnostics\"><\/span><strong>Who bought a stake in Molbio Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> HDFC Mutual Fund acquired 23 lakh shares, a 1.99 percent stake, for Rs 302.45 crore at Rs 1,315 per share.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Who_sold_shares_in_Molbio_Diagnostics\"><\/span><strong>Who sold shares in Molbio Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Business Excellence Trust III, managed by Motilal Oswal Private Equity, sold 23.28 lakh shares for Rs 306.26 crore, trimming its stake by 2.02 percentage points.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_does_Molbio_Diagnostics_do\"><\/span><strong>What does Molbio Diagnostics do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It is a Goa-based company providing diagnostic solutions, known for its molecular point-of-care testing platforms.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Is_the_Molbio_Diagnostics_share_price_expensive\"><\/span><strong>Is the Molbio Diagnostics share price expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E of 91.96 is well above the diagnostics industry average of 66.60, a premium tied to the company&#8217;s position in molecular testing.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_are_the_key_technical_levels_for_the_Molbio_Diagnostics_share_price\"><\/span><strong>What are the key technical levels for the Molbio Diagnostics share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key levels are SuperTrend support at Rs 1,180.54 and the 20-day average of Rs 1,269.32. The RSI is 31.9.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Why_did_a_private_equity_fund_sell_shares_in_Molbio_Diagnostics\"><\/span><strong>Why did a private equity fund sell shares in Molbio Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Private equity funds typically have defined holding periods and return capital to their own investors over time, which is a routine part of their lifecycle rather than necessarily a signal about the company.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Should_I_buy_Molbio_Diagnostics_shares_now\"><\/span><strong>Should I buy Molbio Diagnostics shares now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Continued institutional buying is a positive sign, but the valuation premium is a risk. Use a stop-loss and consult a SEBI-registered adviser.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Molbio Diagnostics share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Molbio Diagnostics share price was Rs 1,313 at 9:13 AM on 1 October 2026, up 0.3 percent from Rs 1,308.90.\"}},{\"@type\":\"Question\",\"name\":\"Who bought a stake in Molbio Diagnostics?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"HDFC Mutual Fund acquired 23 lakh shares, a 1.99 percent stake, for Rs 302.45 crore at Rs 1,315 per share.\"}},{\"@type\":\"Question\",\"name\":\"Who sold shares in Molbio Diagnostics?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Business Excellence Trust III, managed by Motilal Oswal Private Equity, sold 23.28 lakh shares for Rs 306.26 crore, trimming its stake by 2.02 percentage points.\"}},{\"@type\":\"Question\",\"name\":\"What does Molbio Diagnostics do?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It is a Goa-based company providing diagnostic solutions, known for its molecular point-of-care testing platforms.\"}},{\"@type\":\"Question\",\"name\":\"Is the Molbio Diagnostics share price expensive?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E of 91.96 is well above the diagnostics industry average of 66.60, a premium tied to the company's position in molecular testing.\"}},{\"@type\":\"Question\",\"name\":\"What are the key technical levels for the Molbio Diagnostics share price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The key levels are SuperTrend support at Rs 1,180.54 and the 20-day average of Rs 1,269.32. The RSI is 31.9.\"}},{\"@type\":\"Question\",\"name\":\"Why did a private equity fund sell shares in Molbio Diagnostics?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Private equity funds typically have defined holding periods and return capital to their own investors over time, which is a routine part of their lifecycle rather than necessarily a signal about the company.\"}},{\"@type\":\"Question\",\"name\":\"Should I buy Molbio Diagnostics shares now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Continued institutional buying is a positive sign, but the valuation premium is a risk. Use a stop-loss and consult a SEBI-registered adviser.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HDFC Mutual Fund bought a Rs 302 crore stake in Molbio Diagnostics as a PE fund exited. Here is the deal, valuation and risks.<\/p>\n","protected":false},"author":36,"featured_media":281976,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[7085,1019],"class_list":["post-281978","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-block-deals","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["281976"],"rank_math_title":["Molbio Diagnostics Share Price: HDFC MF Buys Rs 302 Cr Stake"],"rank_math_description":["Molbio Diagnostics share price is Rs 1,313, up 0.3%, after HDFC Mutual Fund bought a 1.99% stake for Rs 302 crore as a PE fund trimmed its holding. Levels and risks."],"rank_math_focus_keyword":["Molbio Diagnostics share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/hdfc-mutual-fund-buys-a-rs-302-crore-stake-in-molbio-diagnostics-as-a-motilal.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/281978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=281978"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/281978\/revisions"}],"predecessor-version":[{"id":281979,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/281978\/revisions\/281979"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/281976"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=281978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=281978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=281978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}